Life ScienceCompany
Syngene International M&A Summary
Syngene International has acquired 1 company, including 1 in the last 5 years.
Syngene International’s largest acquisition to date was in 2025, when it acquired Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site for $37M. Syngene International has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Syngene International Business Overview
Where is Syngene International headquartered?
Syngene International is headquartered in Bengaluru, India.
What is Syngene International’s revenue?
Syngene International disclosed revenue of 33,695M INR for 2024 and 30,802M INR for 2023.
How many employees does Syngene International have?
Syngene International has 6,510 employees.
What sector is Syngene International in?
Syngene International is a life science company.
When was Syngene International founded?
Syngene International was founded in 1993.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
